What is the recommended tapering schedule for discontinuing lithium (lithium carbonate) 300 mg twice daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lithium Tapering Protocol for 300 mg Twice Daily

The recommended approach for tapering lithium 300 mg twice daily is to decrease by 10% of the original dose per week, which would mean reducing by approximately 60 mg weekly until discontinuation is complete. 1

General Tapering Guidelines

  • For patients who have been on lithium for a longer duration, a slower taper of 10% per month rather than per week may be more appropriate to minimize withdrawal symptoms 1
  • Tapering should be done in collaboration with the patient, allowing for adjustments based on individual response and tolerance 2
  • Regular follow-up (at least monthly) should be scheduled during the tapering process to monitor for withdrawal symptoms and adjust the taper as needed 2

Specific Tapering Schedule for 300 mg Twice Daily

Standard Approach (10% weekly reduction):

  • Week 1: Reduce to 270 mg twice daily (540 mg total daily dose) 1
  • Week 2: Reduce to 240 mg twice daily (480 mg total daily dose) 1
  • Week 3: Reduce to 210 mg twice daily (420 mg total daily dose) 1
  • Week 4: Reduce to 180 mg twice daily (360 mg total daily dose) 1
  • Continue reducing by approximately 30 mg twice daily each week 1
  • When reaching the smallest available dose, extend the interval between doses before complete discontinuation 2

For Longer-Term Users (10% monthly reduction):

  • Month 1: Reduce to 270 mg twice daily (540 mg total daily dose) 1
  • Month 2: Reduce to 240 mg twice daily (480 mg total daily dose) 1
  • Month 3: Reduce to 210 mg twice daily (420 mg total daily dose) 1
  • Continue this pattern until discontinuation 1

Monitoring During Tapering

  • Watch for withdrawal symptoms including anxiety, insomnia, irritability, and mood changes 2
  • If clinically significant withdrawal symptoms occur, slow the taper rate further 2
  • The taper might need to be paused and restarted when the patient is ready, especially as lower dosages are reached 2

Important Considerations

  • Abrupt discontinuation of lithium should be avoided as it can lead to withdrawal symptoms and increased risk of relapse 2
  • Patients should be advised about the potential for increased risk of mood episode recurrence following lithium discontinuation 1
  • Consider using adjunctive medications to manage withdrawal symptoms if they occur 2
  • For patients struggling with the taper, consider pausing at a stable dose before continuing the reduction 2

Practical Implementation Tips

  • Use available tablet strengths (typically 150 mg, 300 mg, 600 mg) to achieve the target doses during tapering 3
  • When reaching lower doses that cannot be achieved with available tablet strengths, consider alternate-day dosing to achieve the equivalent average daily dose 2
  • Maintain consistent timing of doses during the taper to minimize fluctuations in serum levels 4
  • Ensure adequate hydration and stable sodium intake during the tapering process 5

By following this structured approach to lithium tapering, the risk of withdrawal symptoms and relapse can be minimized while safely discontinuing the medication.

References

Guideline

Lithium Discontinuation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Serum Lithium Levels: Ideal Time for Sample Collection! Are We Doing it Right?

Indian journal of psychological medicine, 2014

Guideline

Lithium Therapy Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.